Brodalumab
Showing 1 - 25 of 57
Hidradenitis Suppurativa, Acne Inversa Trial in New York (Brodalumab)
Completed
- Hidradenitis Suppurativa
- Acne Inversa
- Brodalumab
-
New York, New YorkThe Rockefeller University
Jul 26, 2022
Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)
Recruiting
- Psoriasis Vulgaris
- Venapuncture
- Patient questionnaires
-
Ghent, Oost-Vlaanderen, Belgium
- +6 more
Jan 16, 2023
Psoriasis Vulgaris Trial in Valencia (Brodalumab)
Recruiting
- Psoriasis Vulgaris
- Brodalumab
-
Brussels, Belgium
- +21 more
Dec 12, 2022
Brodalumab in Psoriasis Inadequate Response to Their Current
Completed
- Psoriasis
- Brodalumab
-
Nanaimo, British Columbia, Canada
- +10 more
Jul 13, 2022
Psoriasis Trial in Barcelona, Granada, Pontevedra (Brodalumab, Ustekinumab, Placebo)
Recruiting
- Psoriasis
- Brodalumab
- +2 more
-
Brussels, Bruxelles-Capitale, Belgium
- +21 more
Jan 27, 2023
Psoriasis Trial in United States (Brodalumab)
Recruiting
- Psoriasis
- Brodalumab
-
San Diego, California
- +4 more
Sep 29, 2021
Psoriasis Trial in Bridgewater (Brodalumab, Comparator Drug (non-biologic IL-17 inhibitors))
Enrolling by invitation
- Psoriasis
- Brodalumab
- Comparator Drug (non-biologic IL-17 inhibitors)
-
Bridgewater, New JerseyRegistry
Dec 14, 2021
Molecular Signatures in Inflammatory Skin Disease
Recruiting
- Atopic Dermatitis
- Psoriasis
- Ustekinumab
- +9 more
-
Kiel, GermanyDepartment of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022
Plaque Psoriasis, Psoriasis Vulgaris, Psoriasis Trial in Worldwide (Brodalumab, Placebo, Guselkumab)
Completed
- Plaque Psoriasis
- +2 more
- Brodalumab
- +2 more
-
Wien, Austria
- +52 more
Jan 11, 2023
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
Moderate to Severe Plaque Psoriasis Trial in China (KHK4827-Active, KHK4827-Placebo)
Withdrawn
- Moderate to Severe Plaque Psoriasis
- KHK4827-Active
- KHK4827-Placebo
-
Changchun, China
- +24 more
Sep 24, 2021
Palmoplantar Psoriasis Trial (Brodalumab)
Unknown status
- Palmoplantar Psoriasis
- Brodalumab
- (no location specified)
Nov 12, 2020
Psoriasis Trial (Fecal sample collection)
Unknown status
- Psoriasis
- Fecal sample collection
- (no location specified)
Dec 17, 2020
Hidradenitis Suppurativa Trial in New York (Brodalumab)
Withdrawn
- Hidradenitis Suppurativa
- Brodalumab
-
New York, New YorkRockefeller University Hospital
Sep 2, 2020
Hidradenitis Suppurativa Trial in New York (Brodalumab)
Completed
- Hidradenitis Suppurativa
- Brodalumab
-
New York, New YorkRockefeller Unviersity
Jun 3, 2020
Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris Trial in Tokyo (Brodalumab 210mg SC)
Completed
- Psoriasis Vulgaris
- +3 more
- Brodalumab 210mg SC
-
Tokyo, JapanThe Jikei University Scoole of Medicine
Dec 5, 2019
Psoriatic Arthritis Trial in Worldwide (210 mg brodalumab, 140 mg brodalumab, Placebo)
Completed
- Psoriatic Arthritis
- 210 mg brodalumab
- +2 more
-
Peoria, Arizona
- +102 more
Aug 8, 2020
Psoriasis Trial in Aarhus (Brodalumab, Placebos)
Unknown status
- Psoriasis
- Brodalumab
- Placebos
-
Aarhus, DenmarkAarhus University Hospital
Jul 9, 2019